Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7210
+0.0079 (1.11%)
At close: Sep 4, 2026, 4:00 PM EDT
0.7100
-0.0110 (-1.53%)
After-hours: Sep 4, 2026, 4:30 PM EDT
Daré Bioscience Employees
As of December 31, 2025, Daré Bioscience had 24 total employees, including 21 full-time and 3 part-time employees. The number of employees increased by 1 or 4.35% compared to the previous year.
Employees
24
Change (1Y)
1
Growth (1Y)
4.35%
Revenue / Employee
$56,914
Profits / Employee
-$457,798
Market Cap
11.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | 1 | 4.35% | 21 | 3 |
| Dec 31, 2024 | 23 | -3 | -11.54% | 21 | 2 |
| Dec 31, 2023 | 26 | -4 | -13.33% | 23 | 3 |
| Dec 31, 2022 | 30 | 2 | 7.14% | 25 | 5 |
| Dec 31, 2021 | 28 | 5 | 21.74% | 20 | 8 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| BioLineRx | 24 |
| PDS Biotechnology | 21 |
| IN8bio | 18 |
| Moleculin Biotech | 17 |
| Theriva Biologics | 16 |
| Kiora Pharmaceuticals | 13 |
| Azitra | 13 |
DARE News
- 4 days ago - Dare Bioscience announces new $908,000 NIH funding award to advance DARE-PTB2 - TheFly
- 4 days ago - Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth - GlobeNewsWire
- 8 days ago - Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series - GlobeNewsWire
- 9 days ago - Daré Bioscience Transcript: Investor update - Transcripts
- 9 days ago - Daré Bioscience's Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society - GlobeNewsWire
- 9 days ago - Daré Bioscience Registration statement: Registration filing - Filings
- 10 days ago - Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment - GlobeNewsWire
- 17 days ago - DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List - GlobeNewsWire